99 Episodio

  1. Targeted therapy for BRAF-mutant pediatric glioma

    Pubblicato: 17/06/2022

  2. Early/evolving IDH wild-type glioblastoma

    Pubblicato: 20/05/2022

  3. PI3K signaling in IDH mutant gliomas

    Pubblicato: 06/05/2022

  4. Cell-free DNA from CSF in pediatric, adolescent and young adult patients

    Pubblicato: 22/04/2022

  5. Molecular determinants of neurocognitive deficits in glioma

    Pubblicato: 08/04/2022

  6. H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    Pubblicato: 25/03/2022

  7. Clinical trial accrual for women and minorities in neuro-oncology

    Pubblicato: 11/03/2022

  8. The clinical utility of next generation sequencing for IDHwt glioblastoma

    Pubblicato: 11/02/2022

  9. Trabectedin for recurrent grade 2 or 3 meningiomas

    Pubblicato: 28/01/2022

  10. Glioblastoma cell heterogeneity and plasticity

    Pubblicato: 14/01/2022

  11. Moleculary integrated grading for meningioma

    Pubblicato: 24/12/2021

  12. BOLD fMRI in IDH mutant gliomas

    Pubblicato: 10/12/2021

  13. Glioblastoma subtypes and response to Dasatinib

    Pubblicato: 26/11/2021

  14. Resection for recurrent brain metastases

    Pubblicato: 12/11/2021

  15. Incidental Meningiomas

    Pubblicato: 29/10/2021

  16. Immunosuppression in IDH mutant gliomas

    Pubblicato: 15/10/2021

  17. Immunotherapy for melanoma brain metastases

    Pubblicato: 01/10/2021

  18. DNA methylation profiles within the CATNON trial

    Pubblicato: 17/09/2021

  19. 18F FET PET in childhood CNS tumors

    Pubblicato: 03/09/2021

  20. Checkpoint blockade in atypical meningiomas

    Pubblicato: 20/08/2021

4 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site